JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB3572

Anti-Cytochrome P450 3A4/CYP3A4 antibody

Be the first to review this product! Submit a review

|

(39 Publications)

Rabbit Polyclonal Cytochrome P450 3A4/CYP3A4 antibody. Suitable for WB and reacts with Mouse, Rat, Human samples. Cited in 39 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human CYP3A4.

View Alternative Names

CYP3A3, CYP3A4, Cytochrome P450 3A4, Albendazole monooxygenase (sulfoxide-forming), Albendazole sulfoxidase, CYPIIIA3, CYPIIIA4, Cholesterol 25-hydroxylase, Cytochrome P450 3A3, Cytochrome P450 HLp, Cytochrome P450 NF-25, Cytochrome P450-PCN1, Nifedipine oxidase, Quinine 3-monooxygenase

4 Images
Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody (AB3572)
  • WB

Supplier Data

Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody (AB3572)

All lanes:

Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody (ab3572) at 1/2000 dilution

Lane 1:

Mouse liver at 30 µg

Lane 2:

Rat liver at 30 µg

Secondary

All lanes:

HRP conjugated Goat anti-Rabbit IgG (H+L) at 1/5000 dilution

Predicted band size: 57 kDa

false

Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody (AB3572)
  • WB

Supplier Data

Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody (AB3572)

Electrophoresed on 4-12% BisTris gel transferred onto a nitrocellulose membrane

All lanes:

Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody (ab3572) at 1/2000 dilution

Lane 1:

Mouse liver tissue extract at 30 µg

Lane 2:

Rat liver tissue extract at 30 µg

Lane 3:

Mouse stomach tissue extract at 30 µg

Lane 4:

Rat stomach tissue extract at 30 µg

Secondary

All lanes:

Goat anti-Rabbit IgG (H+L) Superclonal™ Recombinant Secondary Antibody, HRP at 1/4000 dilution

Predicted band size: 57 kDa

Observed band size: 52 kDa

true

Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody (AB3572)
  • WB

Unknown

Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody (AB3572)

Western blot of Cytochrome P450 3A4/CYP3A4 on rat liver extract using ab3572.

All lanes:

Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody (ab3572)

Predicted band size: 57 kDa

false

Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody (AB3572)
  • WB

Unknown

Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody (AB3572)

ab3572 at a dilution of 1/2000 staining Cytochrome P450 3A4/CYP3A4 in rat liver extract by Western blot.

All lanes:

Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody (ab3572)

Predicted band size: 57 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB

applications

Immunogen

Recombinant Full Length Protein corresponding to Human CYP3A4.

P08684

Specificity

ab3572 detects cytochrome P450 (CYP) 3A4 in human and rat tissues and cells. It also shows cross-reactivity with other P450 isoforms to a lesser extent. Since mice do not express CYP3A4, the bands observed in mouse western blot samples correspond to CYP3A9 and CYP3A1.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p>A 46kDa band is detected in rat liver extracts.</p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p>A 46kDa band is detected in rat liver extracts.</p>" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p>A 46kDa band is detected in rat liver extracts.</p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Precipitation Ammonium Sulphate
Storage buffer
Preservative: 0.05% Sodium azide Constituents: PBS, 0.1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Cytochrome P450 3A4 also known as CYP3A4 is an enzyme that plays an important role in the metabolism of many xenobiotics and endogenous compounds. It belongs to the cytochrome P450 superfamily and is a monooxygenase with a mass of approximately 57 kDa. CYP3A4 is primarily expressed in the liver and small intestine although it can be found in other tissues at lower levels. This enzyme catalyzes the oxidation of a wide variety of structurally unrelated compounds facilitating their excretion. Proadifen is a known inhibitor of CYP3A4 often used in research to study the effects of enzyme inhibition.
Biological function summary

CYP3A4 is involved in the metabolism of approximately half of all drugs used in clinical settings making it one of the most significant enzymes in drug metabolism. It does not usually function as part of a larger complex but acts individually on various substrates. Besides xenobiotic metabolism CYP3A4 also metabolizes steroids and other endogenous molecules. Climbazole an antifungal agent is a substrate for CYP3A4 demonstrating the enzyme's broad substrate specificity within the body's complex biochemical environment.

Pathways

CYP3A4 plays a central role in the drug metabolism pathway and the synthesis and metabolism of steroids. These pathways involve other cytochrome P450 enzymes including CYP2D6 and CYP2C9 which often work alongside CYP3A4 to metabolize compounds. The pathway's coordinated activities ensure proper drug metabolism and hormone regulation. Understanding the involvement of CYP3A4 in these pathways is critical for drug development and determining drug-drug interactions.

CYP3A4 is associated with conditions such as drug-induced liver injury and variable drug responses. Alterations in CYP3A4 activity can lead to either toxic accumulations or reduced efficacy of medications. Additionally certain liver diseases can alter CYP3A4 expression further complicating treatment outcomes. The enzyme's interaction with other proteins like those of the cytochrome P450 family means that any dysfunctions can impact a wide range of metabolic processes and influence disease progression.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

A cytochrome P450 monooxygenase involved in the metabolism of sterols, steroid hormones, retinoids and fatty acids (PubMed : 10681376, PubMed : 11093772, PubMed : 11555828, PubMed : 12865317, PubMed : 14559847, PubMed : 15373842, PubMed : 15764715, PubMed : 19965576, PubMed : 20702771, PubMed : 21490593, PubMed : 21576599). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds (PubMed : 12865317, PubMed : 14559847, PubMed : 15373842, PubMed : 15764715, PubMed : 21490593, PubMed : 21576599, PubMed : 2732228). Exhibits high catalytic activity for the formation of hydroxyestrogens from estrone (E1) and 17beta-estradiol (E2), namely 2-hydroxy E1 and E2, as well as D-ring hydroxylated E1 and E2 at the C-16 position (PubMed : 11555828, PubMed : 12865317, PubMed : 14559847). Plays a role in the metabolism of androgens, particularly in oxidative deactivation of testosterone (PubMed : 15373842, PubMed : 15764715, PubMed : 22773874, PubMed : 2732228). Metabolizes testosterone to less biologically active 2beta- and 6beta-hydroxytestosterones (PubMed : 15373842, PubMed : 15764715, PubMed : 2732228). Contributes to the formation of hydroxycholesterols (oxysterols), particularly A-ring hydroxylated cholesterol at the C-4beta position, and side chain hydroxylated cholesterol at the C-25 position, likely contributing to cholesterol degradation and bile acid biosynthesis (PubMed : 21576599). Catalyzes bisallylic hydroxylation of polyunsaturated fatty acids (PUFA) (PubMed : 9435160). Catalyzes the epoxidation of double bonds of PUFA with a preference for the last double bond (PubMed : 19965576). Metabolizes endocannabinoid arachidonoylethanolamide (anandamide) to 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid ethanolamides (EpETrE-EAs), potentially modulating endocannabinoid system signaling (PubMed : 20702771). Plays a role in the metabolism of retinoids. Displays high catalytic activity for oxidation of all-trans-retinol to all-trans-retinal, a rate-limiting step for the biosynthesis of all-trans-retinoic acid (atRA) (PubMed : 10681376). Further metabolizes atRA toward 4-hydroxyretinoate and may play a role in hepatic atRA clearance (PubMed : 11093772). Responsible for oxidative metabolism of xenobiotics. Acts as a 2-exo-monooxygenase for plant lipid 1,8-cineole (eucalyptol) (PubMed : 11159812). Metabolizes the majority of the administered drugs. Catalyzes sulfoxidation of the anthelmintics albendazole and fenbendazole (PubMed : 10759686). Hydroxylates antimalarial drug quinine (PubMed : 8968357). Acts as a 1,4-cineole 2-exo-monooxygenase (PubMed : 11695850). Also involved in vitamin D catabolism and calcium homeostasis. Catalyzes the inactivation of the active hormone calcitriol (1-alpha,25-dihydroxyvitamin D(3)) (PubMed : 29461981).
See full target information CYP3A4

Publications (39)

Recent publications for all applications. Explore the full list and refine your search

Biomedical chromatography : BMC 39:e6056 PubMed39628091

2024

Effects of CYP3A4 Variants on Methadone Metabolism In Vitro.

Applications

Unspecified application

Species

Unspecified reactive species

Chen-Chen Wang,Ming-Lei Zhang,Yan-Dan Xu,Guo-Xin Hu,Jian-Ping Cai,Tian Lan,Yong-Feng Bai

Scientific reports 14:21433 PubMed39271730

2024

Differential genotoxicity of Polygoni Multiflori in rat and human: insights from Ames test and S9 metabolic activation system.

Applications

Unspecified application

Species

Unspecified reactive species

Su-Min Bak,Seng-Min Back,Da Yeon Kim,Soyoung Jung,Na-Young Jeung,Nan-Young Kim,Kang-Hyun Han,Yong-Bum Kim,Byoung-Seok Lee,Jun Hong Park,Hee Jun Cho,Hee Gu Lee,Ozkan Ozden,Sang Kyum Kim,Seong-Hoon Park

Journal of biomedical research 37:431-447 PubMed37990879

2023

Cisplatin increases carboxylesterases through increasing PXR mediated by the decrease of DEC1.

Applications

Unspecified application

Species

Unspecified reactive species

Minqin Xu,Lihua Zhang,Lan Lin,Zhiyi Qiang,Wei Liu,Jian Yang

The Journal of clinical investigation 133: PubMed37581940

2023

Adverse outcomes in SARS-CoV-2-infected pregnant mice are gestational age-dependent and resolve with antiviral treatment.

Applications

Unspecified application

Species

Unspecified reactive species

Patrick S Creisher,Jamie L Perry,Weizhi Zhong,Jun Lei,Kathleen R Mulka,W Hurley Ryan,Ruifeng Zhou,Elgin H Akin,Anguo Liu,Wayne Mitzner,Irina Burd,Andrew Pekosz,Sabra L Klein

British journal of pharmacology 180:2973-2988 PubMed37403641

2023

Role of circadian clock in the chronoefficacy and chronotoxicity of clopidogrel.

Applications

Unspecified application

Species

Unspecified reactive species

Luyao Ma,Fangjun Yu,Di He,Lianxia Guo,Yu Yang,Wangchun Li,Tianpeng Zhang

The American journal of pathology 193:1762-1775 PubMed36822267

2023

Selective Modulation of the Keratoconic Stromal Microenvironment by FSH and LH.

Applications

Unspecified application

Species

Unspecified reactive species

Paulina Escandon,Sarah E Nicholas,Brenda Vasini,Rebecca L Cunningham,David A Murphy,Kamran M Riaz,Dimitrios Karamichos

Scientific reports 12:21825 PubMed36528753

2022

Periportal steatosis in mice affects distinct parameters of pericentral drug metabolism.

Applications

Unspecified application

Species

Unspecified reactive species

Mohamed Albadry,Sebastian Höpfl,Nadia Ehteshamzad,Matthias König,Michael Böttcher,Jasna Neumann,Amelie Lupp,Olaf Dirsch,Nicole Radde,Bruno Christ,Madlen Christ,Lars Ole Schwen,Hendrik Laue,Robert Klopfleisch,Uta Dahmen

Evidence-based complementary and alternative medicine : eCAM 2022:2481654 PubMed36285162

2022

Mechanisms Underlying the Differences in the Pharmacokinetics of Six Active Constituents of Huangqi Liuyi Decoction between Normal and Diabetic Nephropathy Mouse Models.

Applications

Unspecified application

Species

Unspecified reactive species

Qun Wang,Yonglin Wang,Wen Liu,Dingyan Lu,Yang Jin,Nian Tang,Ya Shi,Zipeng Gong,Weiyi Tian,Ting Liu

Frontiers in pharmacology 13:977370 PubMed36188572

2022

Regulation of CYP450 and drug transporter mediated by gut microbiota under high-altitude hypoxia.

Applications

Unspecified application

Species

Unspecified reactive species

Xue Bai,Jianxin Yang,Guiqin Liu,Junbo Zhu,Qian Wang,Wenqi Gu,Linli La,Xiangyang Li

Chemical & pharmaceutical bulletin 70:805-811 PubMed36070932

2022

Hepatoprotective Effects of Phloridzin against Isoniazid-Rifampicin Induced Liver Injury by Regulating CYP450 and Nrf2/HO-1 Pathway in Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Jiao Yang,Guorong Li,Xiaoai Bao,Yujie Suo,Hailong Xu,Ying Deng,Tianyan Feng,Gaigai Deng
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com